Intersect ENT
Intersect ENT offers integrated, less invasive, and cost-effective technologies for chronic rhinosinusitis, including the PROPEL range of sinus implants and SINUVA.
Services
Intersect ENT offers integrated technologies tailored for patients suffering from chronic rhinosinusitis. Their range of less invasive and more cost-effective solutions aims to improve patient outcomes by minimizing the need for traditional surgical interventions.
Products
Intersect ENT produces several sinus implants designed to treat chronic rhinosinusitis. Key products include PROPEL, PROPEL Mini, and PROPEL Contour, all of which are available in the US and EU markets. Another notable product is SINUVA, with specific prescribing information provided for the US market.
Registered Trademarks
PROPEL and INTERSECT ENT are registered trademarks owned by the company in the United States and other countries. These trademarks reinforce their brand identity and protect their innovative sinus implant products.
Headquarters
Intersect ENT is headquartered at 1555 Adams Drive, Menlo Park, CA 94025. This location serves as the central hub for their operations, including development, management, and distribution of their medical technologies.